FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
Newsletter - April 13, 2017
​
FDA’s Paradigm Shifting Approval of the First “Non-Diagnostic” Test  

Last week, FDA cleared for marketing the first direct to consumer genetic test by 23 and Me and by that changed the way most genetic tests could be approved in future. Genetic tests have been controversial and challenging mainly because the conclusions drawn from genetic markers are seldom definitive. Read More

Who is Faster in Approving FDA or EMA and Why Should it Matter  

An analysis published in the New England Journal of Medicine last week, it was proven with data that overall FDA is much faster than its nearest peer, the European Medicines Agency (EMA) in approving new products. Over the last 5 years, FDA took almost half as long as EMA to approve anti-cancer products, and about two-thirds of the time to approve anti-infectious agents compared to EMA. Read More

Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​




Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2021 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.